André Mercanzini is a prominent figure in the field of longevity research in Switzerland. He serves as a leader at Aleva Neurotherapeutics, where he focuses on innovative approaches to neurotherapeutics. With a strong background in neuroscience and biotechnology, he is dedicated to advancing treatments that enhance quality of life. André's work is pivotal in bridging the gap between scientific research and practical applications in the longevity sector.